InvestorsHub Logo
Followers 61
Posts 7526
Boards Moderated 2
Alias Born 02/10/2010

Re: mogman post# 6206

Monday, 08/04/2014 2:50:36 PM

Monday, August 04, 2014 2:50:36 PM

Post# of 43742
I hadn't heard of the company that makes that experimental serum before the other day mogman. They are:

http://mappbio.com/

And appear to be a small pharma company in San Diego that specializes in developing monoclonal antibody treatments for infectious diseases. They've got development stage (pre Phase I clinical testing) treatment candidates for several viral and for a couple of bacterial-derived toxins on their product development list - including ZMapp for Ebola virus.

They had a flier out last Summer (via work with USAMRIID) descibing some of the positve aspects of this drug candidate on Ebola in Monkeys:

http://www.leafbio.com/PettittAug2013.pdf

Sounds promising as they saw a ~40% recovery in symptomatic monkeys - but the use of this drug in this situation was unusual in humans. I certainly hope it does work - and that it can be produced in quanity by the company IF it does.

As regards CVM's potential use of the LEAPS system - as I said - it might work very well once the system is 'tuned' to working with Ebola. But - LEAPs is much further behind where it appears that ZMapp is for use in general.

And with the company currently resource limited and focused on H&N Cancer and HPV treatments using the Multikine product - I don't see that end advancing much unless a lot of time, money and resources are thrown at it.

“The two most powerful warriors are patience and time.”
- Leo Nikolaevich Tolstoy

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CVM News